Skip to main content

Viberzi FDA Approval History

FDA Approved: Yes (First approved May 27, 2015)
Brand name: Viberzi
Generic name: eluxadoline
Dosage form: Tablets
Company: Allergan plc
Treatment for: Irritable Bowel Syndrome

Viberzi (eluxadoline) is a mu-opioid receptor agonist indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

Development timeline for Viberzi

May 27, 2015Approval FDA Approves Viberzi (eluxadoline) for Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults
Sep  2, 2014Actavis Announces FDA Acceptance for Filing of NDA for Eluxadoline

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.